Skip to main content
. 2020 Dec 22;28(5):530–541. doi: 10.1111/acem.14187

Table 2.

Primary Outcome and Secondary Outcomes

At 30 Minutes At 60 Minutes At 120 Minutes
COT (n = 18) NHF (n = 19) Difference (95% CI); p‐value COT (n = 18) NHF (n = 19) Difference (95% CI); p‐value COT (n = 18) NHF (n = 19) Difference (95% CI); p‐value
Patient‐reported outcomes
MBS 5.9 ± 2.3 5.2 ± 2.1 0.7 (–1.3 to 2.6); p = 0.27 4.2 ± 2.8 2.8 ± 2.2 1.4 (–0.5 to 3.3); p = 0.27 3.3 ± 2.5 1.4 ± 2.5 1.9 (0.2 to 3.8); p = 0.043
NRS 5.8 ± 2.4 5.1 ± 2.0 0.9 (–1.1 to 2.8); p = 0.76 4.2 ± 2.8 2.7 ± 2.3 1.6 (–0.4 to 3.5); p = 0.17 3.2 ± 2.5 1.4 ± 2.5 1.9 (0.3 to 3.8); p = 0.044
Comfort score* 6.1 ± 1.6 9.1 ± 1.3 –3.0 (–4.0 to –2.0); p < 0.0001
Physician‐reported outcome and physiologic variables
Dyspnea score 3.8 ± 2.2 2.9 ± 1.6 0.6 (–1.0 to 2.2); p = 0.90 3.1 ± 2.3 1.7 ± 2.1 1.4 (–0.4 to 2.9); p = 0.25 3.1 ± 2.5 1.4 ± 2.5 1.8 (0.4 to 3.6); p = 0.04
Respiratory rate 28.2 ± 5.3 25.1 ± 2.7 2.4 (–0.8 to 5.5); p = 0.26 26.1 ± 4.4 22.4 ± 2.4 2.9 (–0.3 to 6.0); p = 0.09 25.1 ± 4.2 19.7 ± 2.9 4.7 (1.5 to 7.8); p = 0.001
Pulse oximetry 96.3 ± 2.5 97.7 ± 2.0 –1.4 (–3.3 to 0.6); p = 0.35 97.2 ± 2.4 98.0 ± 1.8 ‐0.8 (–2.8 to 1.2); p = 0.86 97.3 ± 2.6 98.5 ± 1.3 –1.2 (–3.2 to 0.8); p = 0.49
Heart rate 106.3 ± 16.1 105.7 ± 20.2 3.2 (–7.8 to 14.1); p = 0.96 104.6 ± 13.8 103.0 ± 19.3 4.3 (–6.6 to 15.2); p = 0.85 100.1 ± 11.5 101.2 ± 19.3 1.3 (–9.6 to 12.2); p = 0.99
Mean arterial pressure 94.8 ± 12.1 99.0 ± 15.5 –2.6 (–12.2 to 6.9); p = 0.97 91.5 ± 11.6 93.2 ± 13.2 –0.1 (–9.7 to 9.4); p = 0.99 86.7 ± 9.4 97.3 ± 16.6 –9.1 (–18.6 to 0.5); p = 0.07

Data are presented as mean ± SD. Covariance structure of first‐order autoregressive was the most parsimonious for most outcomes except heterogenous autoregressive for the dyspnea scale

COT = conventional oxygen therapy; MBS = modified Borg scale; NHF = nasal high flow; NRS = numeric rating scale.

*

COT(n = 17), NHF (n = 18).